Details of the Drug

General Information of Drug (ID: DMJOFLL)

• Drug Name: Rexlemestrocel-L
• Synonyms: MPC-150-M

Indication

Disease Entry	ICD 11	Status	REF
Intervertebral disc degeneration	FA80	Phase 3	[1]

• Drug Type: Cell therapy
• Cross-matching ID:
  UNII: 4LS0IJZ59V
  DrugBank ID: DB17606
  TTD ID: DHV2L8

References

• [1] ClinicalTrials.gov (NCT02412735) Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Subjects With Chronic Low Back Pain (MSB-DR003). U.S. National Institutes of Health.